Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25


AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration-resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first-line therapy.

Zhao J, Zhang M, Liu J, Liu Z, Shen P, Nie L, Guo W, Cai D, Liu J, Armstrong CM, Sun G, Chen J, Zhu S, Dai J, Zhang H, Zhao P, Zhang X, Yin X, Zhu X, Ni Y, Chen N, Zeng H.

Prostate. 2019 Jul 11. doi: 10.1002/pros.23875. [Epub ahead of print]


Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma.

Zhang X, Yin X, Zhang H, Sun G, Yang Y, Chen J, Zhu X, Zhao P, Zhao J, Liu J, Chen N, Wang J, Shen P, Zeng H.

BMC Cancer. 2019 Apr 16;19(1):360. doi: 10.1186/s12885-019-5578-4.


Factors to transcatheter arterial chemoembolization Liver Cancer stage C.

Liu K, Zhou C, Lv W, Cheng D, Lu D, Zhang Z, Xiao J, Zhang X, Fang W.

Minim Invasive Ther Allied Technol. 2019 Mar 8:1-7. doi: 10.1080/13645706.2019.1575241. [Epub ahead of print]


Intrinsic strain-induced segregation in multiply twinned Cu-Pt icosahedra.

Deng L, Liu X, Zhang X, Wang L, Li W, Song M, Tang J, Deng H, Xiao S, Hu W.

Phys Chem Chem Phys. 2019 Feb 27;21(9):4802-4809. doi: 10.1039/c8cp06327c.


The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate Cancer.

Zhao J, Liu J, Sun G, Zhang M, Chen J, Shen P, Liu Z, Liao B, Zhang X, Gong J, Chen N, Zeng H; Collaborators.

J Urol. 2019 Apr;201(4):759-768. doi: 10.1016/j.juro.2018.10.016.


Revealing the Reaction Mechanism of Sodium Selenide Confined within a Single-Walled Carbon Nanotube: Implications for Na-Se Batteries.

Wang L, Zhang X, Deng L, Tang J, Deng H, Hu W, Liu Z.

ACS Appl Mater Interfaces. 2019 Feb 6;11(5):4995-5002. doi: 10.1021/acsami.8b18555. Epub 2019 Jan 28.


Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma.

Zhang X, Yin X, Zhang H, Sun G, Yang Y, Chen J, Shu K, Zhao J, Zhao P, Chen N, Wang J, Shen P, Zeng H.

BMC Cancer. 2019 Jan 10;19(1):49. doi: 10.1186/s12885-019-5273-5.


The effect of additional chemotherapy on high-risk prostate cancer: a systematic review and meta-analysis.

Chen J, Zhang X, Sun G, Zhao J, Liu J, Zhao P, Dai J, Shen P, Zeng H.

Onco Targets Ther. 2018 Dec 13;11:9061-9070. doi: 10.2147/OTT.S187239. eCollection 2018. Review.


Monitoring of Non-Ferrous Wear Debris in Hydraulic Oil by Detecting the Equivalent Resistance of Inductive Sensors.

Zeng L, Zhang H, Wang Q, Zhang X.

Micromachines (Basel). 2018 Mar 8;9(3). pii: E117. doi: 10.3390/mi9030117.


What kind of patients with castration-naïve prostate cancer can benefit from upfront docetaxel and abiraterone: A systematic review and a network meta-analysis.

Sun G, Zhang X, Chen J, Liao B, Liu Z, Zhao J, Gao AC, Yang Y, Shu K, Liu J, Zhao P, Shen P, Zeng H.

Urol Oncol. 2018 Dec;36(12):505-517. doi: 10.1016/j.urolonc.2018.09.005. Epub 2018 Oct 11.


Improved Long-Term Clinical Outcomes And Safety Profile Of Sunitinib Dosing Schedule With 4/2 Switched To 2/1 In Patients With Metastatic Renal Cell Carcinoma.

Zhang X, Sun G, Zhao J, Shu K, Zhao P, Liu J, Yang Y, Tang Q, Chen J, Shen P, Wang J, Zeng H.

J Cancer. 2018 Sep 7;9(18):3303-3310. doi: 10.7150/jca.25693. eCollection 2018.


Sunitinib rechallenge with dose escalation in progressive metastatic renal cell carcinoma: A case report and literature review.

Zhang X, Shen P, Yao J, Chen N, Liu J, Zeng H.

Medicine (Baltimore). 2018 Aug;97(31):e11565. doi: 10.1097/MD.0000000000011565. Review.


Synergetic effect of H and He impurities in Ti3AlC2: first principles calculations.

Liu J, Wang C, Zhu X, Liu J, Zhang X, Gou X, Duan W, Yang L.

Phys Chem Chem Phys. 2018 Jul 11;20(27):18766-18774. doi: 10.1039/c8cp02082e.


Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer.

Zhao J, Sun G, Liao B, Zhang X, Armstrong CM, Yin X, Liu J, Chen J, Yang Y, Zhao P, Tang Q, Wang Z, Chen Z, Li X, Wei Q, Li X, Chen N, Gao AC, Shen P, Zeng H.

BJU Int. 2018 Dec;122(6):994-1002. doi: 10.1111/bju.14398. Epub 2018 Jun 7.


Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis.

Chen J, Zhang H, Sun G, Zhang X, Zhao J, Liu J, Shen P, Shi M, Zeng H.

Int J Surg. 2018 Apr;52:214-220. doi: 10.1016/j.ijsu.2018.02.049. Epub 2018 Feb 27. Review.


The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy.

Zhao J, Shen P, Sun G, Chen N, Liu J, Tang X, Huang R, Cai D, Gong J, Zhang X, Chen Z, Li X, Wei Q, Zhang P, Liu Z, Liu J, Zeng H.

Oncotarget. 2017 Jul 24;8(33):55374-55383. doi: 10.18632/oncotarget.19520. eCollection 2017 Aug 15.


Real-Time Two-Dimensional Magnetic Particle Imaging for Electromagnetic Navigation in Targeted Drug Delivery.

Le TA, Zhang X, Hoshiar AK, Yoon J.

Sensors (Basel). 2017 Sep 7;17(9). pii: E2050. doi: 10.3390/s17092050.


A Novel On-Chip Impedance Sensor for the Detection of Particle Contamination in Hydraulic Oil.

Zhang H, Zeng L, Teng H, Zhang X.

Micromachines (Basel). 2017 Aug 14;8(8). pii: E249. doi: 10.3390/mi8080249.


The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis.

Zhang X, Yin X, Shen P, Sun G, Yang Y, Liu J, Chen N, Zeng H.

Onco Targets Ther. 2017 Jun 22;10:3123-3130. doi: 10.2147/OTT.S127317. eCollection 2017.


The impact of multifocal perineural invasion on biochemical recurrence and timing of adjuvant androgen-deprivation therapy in high-risk prostate cancer following radical prostatectomy.

Sun G, Huang R, Zhang X, Shen P, Gong J, Zhao J, Liu J, Tang Q, Shu K, Yin X, Chen N, Zeng H.

Prostate. 2017 Sep;77(12):1279-1287. doi: 10.1002/pros.23388. Epub 2017 Jul 27.


Supplemental Content

Loading ...
Support Center